1991
DOI: 10.1002/mc.2940040209
|View full text |Cite
|
Sign up to set email alerts
|

Expression of retinoic acid α and β receptor genes in liver and hepatocellular carcinoma

Abstract: cDNA probes for human retinoic acid receptors alpha and beta (RAR alpha and RAR beta) were modified for use as specific hybridization probes to study hepatocellular carcinomas (HCC) and cell lines, liver regeneration, and fetal development. RAR beta mRNA was detected at low levels in adult liver and rose markedly during the early phase of liver regeneration. RAR beta mRNA was present at very low levels in HCC and was not detected in fetal liver. In contrast, RAR alpha mRNA was present at low levels in normal l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
0

Year Published

1993
1993
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 41 publications
(39 reference statements)
1
18
0
Order By: Relevance
“…2 and 10), and we propose that this type of defect may also reflect a common mechanism for loss of RAR␤ expression in some epitheliumderived carcinomas, since this same defect has also been described in HeLa cells (7). Loss of RAR␤ expression has also been reported in head and neck squamous carcinoma (43), hepatocellular carcinoma (109), and breast carcinoma (112). The molecular details underlying defective RAR␤ expression in these types of cancer, as well as in other lung cancer cells, remain to be further characterized.…”
Section: Calu1supporting
confidence: 56%
“…2 and 10), and we propose that this type of defect may also reflect a common mechanism for loss of RAR␤ expression in some epitheliumderived carcinomas, since this same defect has also been described in HeLa cells (7). Loss of RAR␤ expression has also been reported in head and neck squamous carcinoma (43), hepatocellular carcinoma (109), and breast carcinoma (112). The molecular details underlying defective RAR␤ expression in these types of cancer, as well as in other lung cancer cells, remain to be further characterized.…”
Section: Calu1supporting
confidence: 56%
“…2,7,[12][13][14][15][16][17][18] Eleven genes were identified in systems other than regenerating liver: butyrate response factor 1, Mdm2, AP endonuclease, Gadd45, glucose regulated protein 78, Fra-2, snoN, monocyte chemoattractant protein-3, membrane glycoprotein gp130, membrane type matrix metalloproteinase 1 and macrophage inflammatory protein. [19][20][21][22][23] An additional 3 genes not previously known to be induced in liver regeneration, were confirmed as IE genes by northern blot analyses: CD14 antigen/LPS receptor, Tristetraproline and A20 zinc finger protein.…”
Section: Resultsmentioning
confidence: 99%
“…In mice, RAR␤ is highly expressed in the developing respiratory epithelium, and its expression coincides with the onset of cytodifferentiation (15). Loss of RAR␤ expression has been reported for a number of epithelial cell-derived malignancies (21,22,27,49,62,65); notably, it is one of the most frequent events observed in lung cancer (21,49), in which NHBE differentiation is aberrant. Moreover, defective RAR␤ expression is an early event in epithelial carcinogenesis (42).…”
Section: Resultsmentioning
confidence: 99%